|
S. no. | Part used | Extract used | Phytochemical constituents | Dose | Animal/human study | Treatment | Reference |
|
1. | Leaves | Methanolic extract | Not reported | (250 and 500 mg/kg b.w, p.o.) | Rat | Diabetes | [22] |
2. | Leaves | Methanolic extract | Not reported | (250 and 500 mg/kg b.w, p.o.) | Rat | Hyperlipidemia in diabetes | [10] |
3. | Leaves | Methanolic extract | Quercetin, β sitosterol, stigmasterol | (10 mg/kg b.w, p.o.) | Rat | Diabetes | [25] |
4. | Leaves | Alcoholic extract (DAE) | Flavanoids, terpenoids, chromane | DAE (100, 200, and 400 mg/kg b.w, p.o.) and chromane (5 and 10 mg/kg b.w, p.o.) | Rat | Diabetes | [21] |
5. | Leaves | Alcoholic extract (DAE) | Flavanoids, terpenoids, chromane | DAE (100, 200, and 400 mg/kg b.w, p.o.) and chromane(5 and 10 mg/kg b.w, p.o.) | Rat | Diabetic neuropathy | [24] |
6. | Leaves | Alcoholic extract (DAE) | Terpenoids-betulinic acid | (100, 200, and 400 mg/kg b.w, p.o.) | Rat | Diabetic nephropathy | [23] |
7. | Fruit | Aqueous and methanolic extract | Alkaloids, flavonoids, glycosides, tannins, terpenes, and saponins | (150–550 mg/kg b.w. p.o.) | Mice | Antihyperglycemic and antioxidant activity | [45] |
8. | Fruit | Dried fruit powder | Tannins and reducing sugar | 30 g/day | Human | Hypoglycemic activity | [35] |
|